Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial

NCT02319187 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Neoplasms

Interventions

DRUG: S1
DRUG: S-1
DRUG: irinotecan

Sponsor

Chinese Academy of Medical Sciences